Matthias Aizenberg

Imagine a world where a single algorithm could predict a patient’s risk of complications before symptoms even appear, slashing hospital readmissions and saving millions in costs. This isn’t science fiction—it’s the promise of artificial intelligence in healthcare, a sector projected to skyrocket at

Imagine a world where diagnosing coronary artery disease, a condition impacting roughly 18 million adults in the United States alone, becomes not only faster but also far more precise, thanks to the marriage of artificial intelligence and medical imaging. This isn’t a distant dream but a reality

Imagine a densely populated Asian city where an unknown pathogen begins to spread silently, threatening to spiral into a full-blown outbreak before health officials even grasp its origins. This scenario, all too common in a world shaped by rapid travel and climate shifts, underscores the urgent

Imagine a world where medical breakthroughs happen at lightning speed, unhindered by the shackles of data privacy concerns or the staggering costs of traditional research methods. This isn't a distant dream but a reality being shaped right now by the potent combination of artificial intelligence

What happens when a federal agency tasked with safeguarding public health faces mounting delays, staff shortages, and industry distrust—all while racing to approve life-saving drugs? The U.S. Food and Drug Administration (FDA) finds itself at this crossroads, turning to a powerful ally: agentic AI.

In Kenya, the heartbeat of advanced medical care rests in tertiary hospitals, yet these critical facilities are often crippled by a dire shortage of resources, outdated equipment, and chronic financial struggles that compromise patient outcomes. Picture a mother in a rural area, waiting anxiously

Setting the Stage for AI in Healthcare Funding Imagine a healthcare landscape where cutting-edge artificial intelligence tools, capable of detecting diseases with unprecedented accuracy, remain on the sidelines due to financial uncertainty. This is the reality facing many providers and innovators

Imagine a world where a simple blood test could spare countless men from the anxiety and risks of unnecessary prostate biopsies, while still catching dangerous cancers early enough to save lives. That vision is becoming reality with the recent approval by the U.S. Food and Drug Administration of a

Imagine a hospital where a single delayed document can stall a life-saving surgery or postpone critical test results for days. In today's fast-paced healthcare environment, such delays are not just inconvenient—they’re dangerous. Fax technology, a seemingly outdated tool, still anchors much of

Picture a reality where millions of women no longer endure nearly a decade of pain and uncertainty before receiving a diagnosis for a condition as debilitating as endometriosis. In Canada, this vision is inching closer to fruition with the pioneering adoption of the ENDOSURE diagnostic test at